| Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation? FM Szymanski, GYH Lip, KJ Filipiak, AE Platek, ... The American journal of cardiology 116 (11), 1781-1788, 2015 | 91 | 2015 |
| Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations—a long-term prospective, cross-sectional cohort study FM Szymanski, KJ Filipiak, AE Platek, A Hrynkiewicz-Szymanska, ... Sleep and Breathing 19, 849-856, 2015 | 78 | 2015 |
| Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction FM Szymański, G Karpiński, AE Płatek, F Majstrak, ... Polish Heart Journal (Kardiologia Polska) 72 (4), 339-344, 2014 | 70 | 2014 |
| Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population FM Szymański, AE Płatek, G Karpiński, E Koźluk, B Puchalski, KJ Filipiak Kardiologia Polska (Polish Heart Journal) 72 (8), 716-724, 2014 | 68 | 2014 |
| Substantial differences between human and ovine mesenchymal stem cells in response to osteogenic media: how to explain and how to manage? I Kalaszczynska, S Ruminski, AE Platek, I Bissenik, P Zakrzewski, ... BioResearch open access 2 (5), 356-363, 2013 | 47 | 2013 |
| Assessment of CHADS2 and CHA2DS2-VASc scores in obstructive sleep apnea patients with atrial fibrillation FM Szymanski, KJ Filipiak, AE Platek, A Hrynkiewicz-Szymanska, ... Sleep and Breathing 19, 531-537, 2015 | 43 | 2015 |
| Occurrence of poor sleep quality in atrial fi brillation patients according to the EHRA score FM Szymanski, KJ Filipiak, G Karpinski, AE Platek, G Opolski Acta Cardiologica 69 (3), 291-296, 2014 | 41 | 2014 |
| Usefulness of the D-dimer concentration as a predictor of mortality in patients with out-of-hospital cardiac arrest FM Szymanski, G Karpinski, KJ Filipiak, AE Platek, ... The American Journal of Cardiology 112 (4), 467-471, 2013 | 41 | 2013 |
| Association of the CHADS2 and CHA2DS2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients A Hrynkiewicz-Szymanska, M Dluzniewski, AE Platek, FM Szymanski, ... Journal of thrombosis and thrombolysis 40, 240-247, 2015 | 36 | 2015 |
| Recommendation for the management of dyslipidemia in Poland—third declaration of Sopot. Interdisciplinary expert position statement endorsed by the Polish Cardiac Society … FM Szymański, M Barylski, B Cybulska, B Wożakowska-Kapłon, ... Cardiology journal 25 (6), 655-665, 2018 | 34 | 2018 |
| Will the COVID-19 pandemic change national security and healthcare in the spectrum of cardiovascular disease? FM Szymanski, C Smuniewski, AE Platek Current problems in cardiology 45 (9), 100645, 2020 | 27 | 2020 |
| Management of dyslipidemia in Poland: interdisciplinary expert position statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The … FM Szymański, A Mickiewicz, G Dzida, I Gorczyca-Głowacka, D Kozłowski, ... Cardiology Journal 29 (1), 1-26, 2022 | 25 | 2022 |
| Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea—validity of the 2MACE score AE Platek, FM Szymanski, KJ Filipiak, A Dudzik-Plocica, B Krzowski, ... Sleep and Breathing 21, 601-606, 2017 | 25 | 2017 |
| Prevalence of Erectile Dysfunction in Atrial Fibrillation Patients: A Cross‐Sectional, Epidemiological Study AE Platek, A Hrynkiewicz‐Szymanska, M Kotkowski, FM Szymanski, ... Pacing and Clinical Electrophysiology 39 (1), 28-35, 2016 | 25 | 2016 |
| Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor AE Platek, A Szymanska Clinical and Experimental Hepatology 9 (1), 2023 | 22 | 2023 |
| Co-treatment of lower urinary tract symptoms and cardiovascular disease–where do we stand? K Semczuk-Kaczmarek, AE Płatek, FM Szymański Central European Journal of Urology 73 (1), 42, 2020 | 18 | 2020 |
| Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea FM Szymanski, GYH Lip, KJ Filipiak, AE Platek, G Karpinski International journal of cardiology 204, 200-205, 2016 | 18 | 2016 |
| Prevalence of hypertension in professional drivers (from the RACER-ABPM Study) AE Platek, FM Szymanski, KJ Filipiak, M Kotkowski, A Rys, ... The American Journal of Cardiology 120 (10), 1792-1796, 2017 | 17 | 2017 |
| Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients? FM Szymański, KJ Filipiak, AE Płatek, M Kotkowski, G Opolski Cardiology journal 22 (4), 446-452, 2015 | 17 | 2015 |
| Leczenie dyslipidemii w Polsce—interdyscyplinarne stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego. IV … FM Szymański, A Mickiewicz, G Dzida, I Gorczyca-Głowacka, D Kozłowski, ... Choroby Serca i Naczyń 18 (3), 95-120, 2021 | 15 | 2021 |
Filip M. SzymanskiFaculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland.Verified email at post.pl
